CLINICAL_TRIALS
trial_result
· 2022-01-19
Clinical Trial Update: PETHEMA LAL-07FRAIL: All Treatment In Fragile Patients Ph' Negative Over 55 Years [Phase 4]
Summary
A Phase 4 clinical trial update for frail, Philadelphia-negative patients over 55 with acute lymphoblastic leukemia.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: PETHEMA Foundation | Conditions: Acute Lymphoblastic Leukemia | Phase 4 | Status: UNKNOWN